Nestin expression in brain tumors: Its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomas

Brain Tumor Pathology

Volumn 29, Issue 3, 2012, Pages 160-167

  Arai, Hideo ^a,b   Ikota, Hayato ^a   Sugawara, Ken ichi ^a   Nobusawa, Sumihito ^a   Hirato, Junko ^b   Nakazato, Yoichi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

High grade glioma; Immunohistochemistry; Nestin; Pathological diagnosis; Schwannoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ISOCITRATE DEHYDROGENASE 1; NESTIN; PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ASTROCYTOMA; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEURILEMOMA; OLIGODENDROGLIOMA; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; TISSUE MICROARRAY; TISSUE SECTION;

BRAIN NEOPLASMS; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; NEOPLASM GRADING; NERVE TISSUE PROTEINS; NEURILEMMOMA; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84865208822     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-012-0081-5     Document Type: Conference Paper

References (37)

1. Colin C, Virard I, Baeza N et al (2007) Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis. Neuropathol Appl Neurobiol 33:431-439 (Pubitemid 47037890)
2. Gu H, Wang S, Messam CA et al (2002) Distribution of nestin immunoreactivity in the normal adult human forebrain. Brain Res 943:174-180 (Pubitemid 36120377)
3. Johansson CB, Momma S, Clarke DL et al (1999) Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96:25-34 (Pubitemid 29044150)
4. Tohyama T, Lee VM, Rorke LB et al (1992) Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest 66:303-313
5. Tsujimura T, Makiishi-Shimobayashi C, Lundkvist J et al (2001) Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal. Am J Pathol 158:817-823 (Pubitemid 32221774)
6. Carriere C, Seeley ES, Goetze T et al (2007) The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia. Proc Natl Acad Sci USA 104:4437-4442 (Pubitemid 47186244)
7. Flørenes VA, Holm R, Myklebost O et al (1994) Expression of the neuroectodermal intermediate filament nestin in human melanomas. Cancer Res 54:354-356 (Pubitemid 24053166)
8. Kleeberger W, Bova GS, Nielsen ME et al (2007) Roles for the stem cell associated intermediate filament nestin in prostate cancer migration and metastasis. Cancer Res 67:9199-9206 (Pubitemid 47535906)
9. Li H, Cherukuri P, Li N et al (2007) Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res 67:501-510 (Pubitemid 46192186)
10. Dahlstrand J, Collins VP, Lendahl U et al (1992) Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res 52:5334-5341
11. Smits A, van Grieken D, Hartman M et al (1996) Coexpression of platelet-derived growth factor alpha and beta receptors on medulloblastomas and other primitive neuroectodermal tumors is consistent with an immature stem cell and neuronal derivation. Lab Invest 74:188-198
12. You H, Kim YI, Im SY et al (2005) Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma. J Neurooncol 74:1-8 (Pubitemid 41194524)
13. Kim BJ, Kim SS, Kim YI et al (2004) Forskolin promotes astroglial differentiation of human central neurocytoma cells. Exp Mol Med 36:52-56 (Pubitemid 38374724)
14. Ma YH, Mentlein R, Knerlich F et al (2008) Expression of stem cell markers in human astrocytomas of different WHO grades. J Neurooncol 86:31-45 (Pubitemid 350263430)
15. Ikota H, Kinjo S, Yokoo H et al (2006) Systematic immunohis-tochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology. Acta Neuropathol 111:475-482
16. Nakazato Y, Ishizeki J, Takahashi K et al (1982) Localization of S-100 protein and glial fibrillary acidic protein-related antigen in pleomorphic adenoma of the salivary glands. Lab Invest 46:621-626 (Pubitemid 12081999)
17. Louis DN, Ohgaki H, Wiestler OD et al (2007) WHO classification of tumours of the central nervous system. IARC, Lyon
18. Strojnik T, Røsland GV, Sakariassen PO et al (2007) Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: Correlation of nestin with prognosis of patient survival. Surg Neurol 68:133-143 (Pubitemid 47087905)
19. Sarlomo-Rikala M, Tsujimura T, Lendahl U et al (2002) Patterns of nestin and other intermediate filament expression distinguish between gastrointestinal stromal tumors, leiomyomas and schwannomas. APMIS 110:499-507 (Pubitemid 34856492)
20. Shimada S, Tsuzuki T, Kuroda M et al (2007) Nestin expression as a new marker in malignant peripheral nerve sheath tumors. Pathol Int 57:60-67
21. Yokoo H, Nobusawa S, Takebayashi H et al (2004) Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas. Am J Pathol 164:1717-1725 (Pubitemid 38529774)
22. Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765-773
23. Ichimura K, Pearson DM, Kocialkowski S et al (2009) IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. Neuro Oncol 11:341-347
24. Watanabe T, Nobusawa S, Kleihues P, Ohgaki H (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174:1149-1153
25. Nobusawa S, Watanabe T, Kleihues P et al (2009) IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res 15:6002-6007
26. Hartmann C, Hentschel B, Wick W et al (2010) Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: Implications for classification of gliomas. Acta Neuropathol 120:707-718
27. Hartmann C, Meyer J, Balss J et al (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: A study of 1,010 diffuse gliomas. Acta Neuropathol 118:469-474
28. Capper D, Weissert S, Balss J et al (2010) Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol 20:245-254
29. Ikota H, Nobusawa S, Tanaka Y et al (2011) High-throughput immunohistochemical profiling of primary brain tumors and nonneoplastic systemic organs with a specific antibody against the mutant isocitrate dehydrogenase 1 R132H protein. Brain Tumor Pathol 28:107-214
30. Nigro JM, Baker SJ, Preisinger AC et al (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-708 (Pubitemid 20001591)
31. Wong AJ, Bigner SH, Bigner DD et al (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84:6899-6903
32. Ishiwata T, Teduka K, Yamamoto T et al (2011) Neuroepithelial stem cell marker nestin regulates the migration, invasion and growth of human gliomas. Oncol Rep 26:91-99
33. Piras F, Perra MT, Murtas D et al (2010) The stem cell marker nestin predicts poor prognosis in human melanoma. Oncol Rep 23:17-24
34. Tanabe K, Amoh Y, Kanoh M et al (2010) Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma. Eur J Dermatol 20:283-288
35. Zhang M, Song T, Yang L et al (2008) Nestin and CD133: Valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 27:85. doi: 10.1186/1756-9966-27-85
36. Chinnaiyan P, Wang M, Rojiani AM et al (2008) The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group. Radiat Oncol 3:32. doi:10.1186/1748-717X-3-32
37. Kim KJ, Lee KH, Kim HS et al (2011) The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas. Neuropathology 31:494-502